Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...

The 2013 Audi Q3 2.0 TFSI quattro is the Armani suit in the popular small-SUV market segment, offering smart modern styling, German technical expertise, and lots of class and prestige. It is ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...